A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
This study is a phase II, open label, single-arm and exploratory clinical trial. The purpose
of this study is to observe the efficacy and safety of consolidation immunotherapy with
Toripalimab following postoperative radiotherapy or chemoradiotherapy for patients with
locally advanced head and neck squamous cell carcinomas (HNSCC).
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University